Kaplan-Meier analysis comparing overall survival of patients with MDS/AML (RAEB, RAEBt, and AML following MDS) and AML1 point mutations with the survival of patients without an AML1 mutation. The black line indicates patients with an AML1 point mutation; the gray line indicates patients without an AML1 mutation.